Behcet's syndrome and focal segmental glomerulosclerosis with nephrotic syndrome - successful treatment with etanercept

被引:5
作者
Leonard, Deanne [1 ]
Cortese, Cherise [2 ]
Wadei, Hani M. [1 ]
Porter, Ivan E., II [1 ]
Aslam, Nabeel [1 ]
机构
[1] Mayo Clin, Div Nephrol & Hypertens, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Lab Med & Pathol, Jacksonville, FL 32224 USA
关键词
Behcet's syndrome; FSGS; nephrotic syndrome; etanercept; DISEASE;
D O I
10.5414/CN109262
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Behcet's syndrome (BS) often presents with aphthous and genital ulcers, uveitis, and erythema nodosum. Renal involvement has been reported with most cases presenting with renal amyloidosis, IgA nephropathy, or crescentic glomerulonephritis. We describe a case of a 49-year-old woman with relapsing BS symptoms coinciding with new-onset development of nephrotic syndrome. Renal biopsy showed focal segmental glomerulosclerosis (FSGS) that was treated with prednisone and etanercept for BS therapy. Both proteinuria and BS symptoms responded to treatment with complete remission. To our knowledge, our report is the first to show evidence of a possible connection between BS and FSGS and discusses the pathophysiologic mechanism that explains this link.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 18 条
  • [1] Renal Behcet's Disease: An Update
    Akpolat, Tekin
    Dilek, Melda
    Aksu, Kenan
    Keser, Goekhan
    Toprak, Oemer
    Cirit, Mustafa
    Oguz, Yusuf
    Taskapan, Huelya
    Adibelli, Zelal
    Akar, Harun
    Tokgoez, Buelent
    Arici, Mustafa
    Celiker, Hueseyin
    Diri, Banu
    Akpolat, Ilkser
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 38 (03) : 241 - 248
  • [2] Glomerulonephritis in Behcet's disease:: Report of seven cases and review of the literature
    Altiparmak, MR
    Tanverdi, M
    Pamuk, ÖN
    Tunc, R
    Hamuryudan, V
    [J]. CLINICAL RHEUMATOLOGY, 2002, 21 (01) : 14 - 18
  • [3] TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation
    Bitzan, Martin
    Babayeva, Sima
    Vasudevan, Anil
    Goodyer, Paul
    Torban, Elena
    [J]. PEDIATRIC NEPHROLOGY, 2012, 27 (12) : 2217 - 2226
  • [4] Cengiz N, 2003, CLIN NEPHROL, V59, P234
  • [5] Behcet's disease and focal segmental glomerulosclerosis: an unusual association
    Granata, Antonio
    Floccari, Fulvio
    [J]. RHEUMATOLOGY INTERNATIONAL, 2012, 32 (06) : 1853 - 1854
  • [6] International Study Group for Beh~et's Disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-
  • [7] Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
    Joy, Melanie S.
    Gipson, Debbie S.
    Powell, Leslie
    MacHardy, Jacqueline
    Jennette, J. Charles
    Vento, Suzanne
    Pan, Cynthia
    Savin, Virginia
    Eddy, Allison
    Fogo, Agnes B.
    Kopp, Jeffrey B.
    Cattran, Daniel
    Trachtman, Howard
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (01) : 50 - 60
  • [8] Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behcet's disease
    Kose, O.
    Stewart, J.
    Waseem, A.
    Lalli, A.
    Fortune, F.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (01) : 62 - 69
  • [9] Kose Osman, 2012, Patholog Res Int, V2012, P261989, DOI 10.1155/2012/261989
  • [10] The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center
    Kural-Seyahi, E
    Fresko, I
    Seyahi, N
    Ozyazgan, Y
    Mat, C
    Hamuryudan, V
    Yurdakul, S
    Yazici, H
    [J]. MEDICINE, 2003, 82 (01) : 60 - 76